Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy should not be injected straight from the fridge. The Wegovy SmPC and patient information leaflet — the authoritative documents governing how the medicine should be used — advise allowing the pen to reach room temperature before injecting, typically by leaving it out for around 30 minutes. Injecting a cold pen is unlikely to be dangerous, but it can make the injection noticeably more uncomfortable and may affect how smoothly the medicine flows. Wegovy is a prescription-only semaglutide treatment for weight management, and the manufacturer's instructions on temperature are part of the licensed conditions of use, not optional guidance. Your prescriber and the patient information leaflet that comes with your pen are the definitive sources for how to handle your specific device.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Wegovy SmPC (published on the electronic Medicines Compendium and the document that underpins every UK dispensing decision) states that the pen should be allowed to reach room temperature before use. This recommendation exists for two reasons that the clinical literature on subcutaneous injections supports consistently. First, a cold, viscous solution takes more force to push through the needle, which can translate into a slower, more uncomfortable injection and occasionally incomplete dose delivery if the pen mechanism is engaged before the medicine is flowing freely. Second, cooler liquid injected under the skin triggers a localised vasoconstriction response that many people experience as a sharp sting or burning that persists for longer than the injection itself.
The patient information leaflet advises around 30 minutes out of the fridge as a practical guide, though the exact window before the pen must be used (or discarded) is set out clearly in the leaflet for your specific pen format. If you have any doubt about whether a pen has been left out too long, the full guidance on storing Wegovy correctly covers those limits in detail. The NHS's own patient-level semaglutide information reinforces that storage instructions should be followed precisely, citing NHS guidance on semaglutide as the accessible summary for patients.
A question our prescribers hear most weeks is whether it is ever safe to skip the warm-up step on a busy morning. The short answer is that a single cold injection will not harm you, but making it a habit tends to mean more injection-site reactions over time, a pattern worth avoiding when you are using the pen every week for months.
Subcutaneous tissue sits just beneath the skin, and its nerve endings are sensitive to temperature. When cold liquid enters that layer, the body interprets the temperature difference as a mild irritant, producing a sharper initial sensation and sometimes a longer-lasting red wheal at the site. This is not a sign that anything has gone wrong with the medicine or the injection technique, it is a straightforward physiological response.
The three licensed injection sites for Wegovy are the abdomen, the front of the thigh, and the upper arm; rotating between them is recommended to reduce cumulative site reactions. If you have been experiencing more discomfort than you expected, the site you are using is worth reviewing, some areas are naturally more sensitive than others. The guidance on choosing and rotating your semaglutide injection site explains what to consider when picking between locations. Allowing the pen to sit at room temperature before injection is one of the simplest adjustments that can reduce site discomfort substantially, alongside injecting slowly and keeping the skin relaxed.
The same principles apply regardless of which Wegovy pen format you are using. The 2.4mg pen and the newer 7.2mg single-dose pen approved by the MHRA in April 2026 are both pre-filled subcutaneous injections stored under refrigeration, and the temperature advice in their respective leaflets should be read carefully because device-specific details can differ.
Wegovy must be stored at 2–8°C in a refrigerator, not in the freezer, and not near the ice compartment where temperatures can dip below zero. A frozen pen should not be used. Once a pen has been taken out of the fridge for use or for travel, it can be kept below 30°C and away from direct light for a defined period before it must be discarded; that period is stated precisely in the leaflet and on the carton, and it is the figure that governs your pen, not a general rule from a website.
For people asking whether Wegovy always needs to be refrigerated, the answer is yes for storage, but not for the brief warm-up window before each injection. The distinction matters practically: if you travel, a cool bag is appropriate for keeping pens within the cold chain; the 30-minute warm-up on injection day does not require any equipment beyond leaving the pen on a surface.
Questions about cost and access are separate from the storage and injection technique questions this page covers. If you are at an earlier stage and thinking about how to access treatment, the guide to where Wegovy can be obtained in the UK sets out what private prescribing involves. The guidance on timing your weekly Wegovy injection covers the scheduling questions that often come alongside temperature queries.
Getting the injection routine right matters more than many people expect at the start of treatment. A pen at room temperature is the foundation, but there are several other steps that reduce discomfort and injection-site reactions. Clean the skin with an alcohol swab and let it dry fully before injecting, injecting through wet skin stings more. Pinch the skin gently if you have a smaller amount of subcutaneous tissue at the chosen site. Insert the needle in one smooth, deliberate movement and hold the pen in place for the count your leaflet specifies before removing it.
Do not rub the injection site after removing the pen; gentle pressure with a cotton pad is fine if needed. Used pens are sharps and must be disposed of safely. A sharps container is the correct receptacle, household bins are not appropriate, and most councils have sharps disposal points.
If injection-site reactions are persistent, or if you are experiencing any side effects that concern you, your prescriber is the right person to speak to. Semaglutide's known side-effect profile is led by gastrointestinal symptoms (nausea, indigestion, changes in bowel habit) and is described clearly in the NHS patient information for semaglutide. Suspected side effects can also be reported directly to the MHRA via the Yellow Card scheme.
If you are considering semaglutide for weight management and want to understand your options, you can check your eligibility with our prescribers through a free consultation, reviewed the same day by a GPhC-registered clinician, not automated software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.